Abstract

This study investigated the predictive factors for perinatal bacterial transmission in very-low-birth-weight infants (VLBWIs) born to mothers with a history of intrapartum colonization. We retrospectively reviewed the medical records of 173 VLBWIs, wherein pathogens were confirmed in maternal cultures obtained from the blood, urine, and vagina during the intrapartum period from 2013 to 2020. Newborns were categorized based on microbiological tests, including gastric aspirates, endotracheal aspirates, blood, and skin/nasal swab cultures collected immediately after birth. Infants whose cultures matched their maternal pathogens were categorized into the “transmission group” (n = 45), while those who tested negative were assigned to the “control group” (n = 128). The predominant maternal-colonizing pathogen observed was Escherichia coli (30.6%), which also emerged as the primary colonizing pathogen in neonates (35.6%). Transmission group had higher incidences of maternal leukocytosis, chorioamnionitis, and cervical cerclage. Regarding neonatal characteristics, the transmission group demonstrated lower initial base excesses (− 6.3 ± 3.9 vs. − 9.2 ± 4.9, P < 0.05) and higher C-reactive protein levels (0.1 ± 0.3 vs. 0.4 ± 0.8, P < 0.05). Notably, regarding major neonatal outcomes, transmission group had higher mortality rates and incidences of severe intraventricular hemorrhage. These findings may be useful for making decisions when considering antibiotic treatment for infants with a history of maternal colonization.

Details

Title
Predictive factors for perinatal bacterial transmission from colonized mothers to delivered very-low-birth-weight infants: a retrospective cohort study
Author
Hwang, Jieun 1 ; Kim, Sumin 2 ; Kim, Hanna 1 ; Kim, Chan 1 ; Kim, Seung Hyun 1 ; Yang, Misun 3 ; Ahn, So Yoon 3 ; Sung, Se In 3 ; Chang, Yun Sil 4 

 Sungkyunkwan University School of Medicine, Department of Pediatrics, Samsung Medical Center, Seoul, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
 Sungkyunkwan University School of Medicine, Department of Pediatrics, Samsung Medical Center, Seoul, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Department of Clinical Research Design and Evaluation, Seoul, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
 Sungkyunkwan University School of Medicine, Department of Pediatrics, Samsung Medical Center, Seoul, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Medical Center, Cell and Gene Therapy Institute for Future Medicine, Seoul, Republic of Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613) 
 Sungkyunkwan University School of Medicine, Department of Pediatrics, Samsung Medical Center, Seoul, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Medical Center, Cell and Gene Therapy Institute for Future Medicine, Seoul, Republic of Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613); Sungkyunkwan University, Department of Health Science and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Seoul, Republic of Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
Pages
16835
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3083312520
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.